These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8180269)

  • 21. Thrombin interaction with platelet GpIB: role of the heparin binding domain.
    De Candia E; De Cristofaro R; De Marco L; Mazzucato M; Picozzi M; Landolfi R
    Thromb Haemost; 1997 Apr; 77(4):735-40. PubMed ID: 9134652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of A alpha 251 fibrinogen: the alpha C domain has a role in polymerization, albeit more subtle than anticipated from the analogous proteolytic fragment X.
    Gorkun OV; Henschen-Edman AH; Ping LF; Lord ST
    Biochemistry; 1998 Nov; 37(44):15434-41. PubMed ID: 9799505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW
    Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
    Mosesson MW; Hernandez I; Siebenlist KR
    Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin.
    Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of critical residues on thrombin mediating its interaction with fibrin.
    Hall SW; Gibbs CS; Leung LL
    Thromb Haemost; 2001 Dec; 86(6):1466-74. PubMed ID: 11776315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of thrombin in complex with fibrinogen gamma' peptide.
    Pineda AO; Chen ZW; Marino F; Mathews FS; Mosesson MW; Di Cera E
    Biophys Chem; 2007 Feb; 125(2-3):556-9. PubMed ID: 16962697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hydrolysis of methyl esters of N alpha-arylsulfonyl-arginine and N-arylsulfonyl-valyl-arginine by alpha- and beta/gamma-thrombins].
    Strukova SM; Semenova OA; Kireeva EG; Sereĭskaia AA; Romanova VP
    Biokhimiia; 1982 Apr; 47(4):528-33. PubMed ID: 7082687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of exosite occupancy on the substrate specificity of thrombin.
    Ng NM; Quinsey NS; Matthews AY; Kaiserman D; Wijeyewickrema LC; Bird PI; Thompson PE; Pike RN
    Arch Biochem Biophys; 2009 Sep; 489(1-2):48-54. PubMed ID: 19638274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of temperature on thrombin- and trypsin-catalyzed hydrolysis of synthetic substrates].
    Kostiuchenko NV; Romanova VP; Kibirev VK
    Ukr Biokhim Zh (1978); 1987; 59(3):3-7. PubMed ID: 3603730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
    Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational transitions linked to active site ligation in human thrombin: effect on the interaction with fibrinogen and the cleavable platelet receptor.
    De Cristofaro R; De Candia E; Picozzi M; Landolfi R
    J Mol Biol; 1995 Jan; 245(4):447-58. PubMed ID: 7837275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
    Sonder SA; Fenton JW
    Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition.
    Fenton JW; Olson TA; Zabinski MP; Wilner GD
    Biochemistry; 1988 Sep; 27(18):7106-12. PubMed ID: 3196704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional modeling of thrombin-fibrinogen interaction.
    Rose T; Di Cera E
    J Biol Chem; 2002 May; 277(21):18875-80. PubMed ID: 11901150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of temperature on the hydrolysis of some synthetic substrates by thrombin and trypsin].
    Kibirev VK
    Biokhimiia; 1981 Oct; 46(10):1799-806. PubMed ID: 7306600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.